Who owns Graham G. Walmsley?

No ownership or control links for Graham G. Walmsley are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Graham G. Walmsley's risk level?

WhiteIntel flags Graham G. Walmsley as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Graham G. Walmsley appear across sources?

Graham G. Walmsley is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

PersonLow

Graham G. Walmsley

Name: Graham G. Walmsley — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Graham G. Walmsley, Person, US

Graham G. Walmsley — US person (sec:0001777517). 6 holdings. Every claim linked to its source.

controls 6 companies

Ownership graph Export .md

JSON / MCPsample

The finding

Controls or directs 6 companies in the resolved graph.

Investigative lead by resolved identity, not a legal determination.

/01

Registry identity

Controls: 6 companies
Risk: Low
Jurisdiction: US

/02

Control & directorships

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Controlled by

None in current sources.

Directorships & controlled companies

Graham G. Walmsley
- Akero Therapeutics, Inc.· director· via SEC EDGAR (Form 3/4/5)
- Olema Pharmaceuticals, Inc.· director· via SEC EDGAR
- ALX ONCOLOGY HOLDINGS INC· director· via SEC EDGAR
- LIFESCI ACQUISITION II CORP.· director· via SEC EDGAR

Nothing further is withheld here. The ownership and control links above are everything we have resolved for Graham G. Walmsley — there is no deeper chain behind a paywall. Absence means “not observed in our current sources” — it is not a finding of none.

Monitoring

Coverage of Graham G. Walmsley is still thin in the current sources. Watch it and we'll flag the moment new ownership, filings or risk signals land.

Explore US coverage

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, nationality & aliases
Sanctions, PEP & watchlist detail
Direct connections (1 hop)
Community notes

Nothing further on Graham G. Walmsley is behind a paywall — everything we hold on this subject is already on this page.

/03

People & control

4 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
Akero Therapeutics, Inc.
Also holds roles at 43 other companies
- Yale Catrionaofficer
- Cheng Andrewofficer
- Young Jonathanofficer
●
ALX ONCOLOGY HOLDINGS INC
Also holds roles at 48 other companies
- Pinto Shellyofficer
- Lettmann Jasonofficer
- Pons Jaumeofficer
●
LIFESCI ACQUISITION II CORP.
Also holds roles at 65 other companies
- TIWARI NEILother
- SHIPTON MICHAELofficer
- JAGUAR HOLDING CO IItenpercentowner
●
Olema Pharmaceuticals, Inc.
Also holds roles at 76 other companies
- Myles David C.officer
- Zojwalla Naseemofficer
- Mitchell Shawnteofficer

4 parties · 0 current. Ceased and resigned records are retained as history.

/04

Common questions

Who owns Graham G. Walmsley?: No ownership or control links for Graham G. Walmsley are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Graham G. Walmsley's risk level?: WhiteIntel flags Graham G. Walmsley as low risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Graham G. Walmsley appear across sources?: Graham G. Walmsley is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Graham G. Walmsley. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…